Intrauterine Contraceptive Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
Intrauterine contraceptive devices (IUD), often found in T-shape, are inserted in the uterus in order to prevent conception. The arms of the device are fold flat helping to insert inside the womb and its size is like a match stick, so that it fits properly inside the womb. These devices include either copper or levonorgestrel, which helps in birth control by creating difficulty for the sperm to fertilize the egg. Intrauterine contraceptive devices are usually a form of long-acting reversible contraceptives (LARC), which aids in birth control for an extended period of time. The approximate tenure of these devices lie between 5 to 8 years. These devices have resulted in huge satisfaction rates among the users of reversible contraceptives due to their cost-effectiveness. Copper IUD is also used after an unprotected sex as an emergency contraceptive. Intrauterine contraceptive devices do not have a negative impact on breastfeeding, when they are inserted immediately after delivery. These are also used immediately after abortion. Once removed, fertility is restored back to normal. These devices are inserted with the help of healthcare professionals. According to an article published by Patient, a web-based health information platform, IUDs are very effective as 1 to 2 out of every 100 women will become pregnant after 5 years of using the device. The non-users of this device, who are sexually active, become pregnant and the count reaches to 80 out of 100 women within 1 year.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/53
Unplanned pregnancy is a major driver for intrauterine contraceptive devices
Rising prevalence of unplanned pregnancy and less side-effects pertaining to these devices are some of the drivers impacting the demand for intrauterine contraceptive devices market. Moreover, with the use of such devices there is no requirement of a new contraception every day, as in case of contraceptive pills. Moreover, intrauterine contraceptive devices do not impact the user’s mood, libido and weight and does not even carry the risk for cancer in future. However, use of intrauterine contraceptive devices may lead to heavy menstrual bleeding, resulting into painful cramps, which is projected to impede the growth of the market. In addition, the demand for contraceptive pills for shorter period usage is expected to hinder the demand for the devices. Need for continuous assistance of healthcare professionals is also restraining the market towards growth.
Hormonal IUCD has low failure rate as compared to copper IUD
On the basis of product, intrauterine contraceptive devices (IUD) are segmented as hormonal IUD and copper IUD. In the first year of usage of the device, failure rate with hormonal IUD is around 0.2% whereas failure rate with copper IUD is around 0.8%.
Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/53
On the basis of end use, intrauterine contraceptive devices are classified under hospital, gynecology clinics and others. Based on geography, the market is divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Asia Pacific market to enhance the demand for intrauterine contraceptive devices
Asia Pacific is expected to hold a significant share for intrauterine contraceptive devices market owing to the rising number of unplanned pregnancy and thereby, greater usage of such devices in this region. Moreover, rising government initiatives focusing on improved healthcare in Asian countries are also supporting the growth of the market. Furthermore, technological advancements associated with these devices are accentuating their demand in North America, followed by Europe.
Some of the major companies indulging in the production of intrauterine contraceptive devices include Bayer HealthCare AG, Melbea AG, DKT International, Medicines360 and Egemen International among others. these companies are focusing on strategic initiatives and mergers and acquisitions in order to cater to the growing need of the target population. For instance, in 2015, Bayer HealthCare entered into a strategic partnership with Afaxys, Inc. in order to serve women in the U.S. The alliance will include Afaxys’ expertise and Bayer’s intrauterine device to serve the U.S. public health contraception market.
Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/intrauterine-contraceptive-devices-market-53
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #320000A0
Seattle, WA 98154
Visit Blog: http://healthcaremarketconsulting.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intrauterine Contraceptive Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024 here
News-ID: 510028 • Views: 159
More Releases from Medical Devices Market Report
Global ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2025
ENT Disorder Treatment Market – Hear Better, Breathe Better, Live Better ENT also known as otolaryngology is a stream of medical science that deals with disorders associated with ear, nose, and throat. Diseases related to ears, throat, and nose significantly affect the quality of life and could lead to surgeries in few cases such as chronic tonsillitis, ear infections, and severe sinusitis problems as well as cancers of the throat or
Endometrial Ablation Market - Global Industry Insights 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Blood Collection Devices Market - Global Industry Insights 2025
Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In
Casting and Splinting Products Market - Global Industry Insights 2025
Casts and splints are designed to protect and support injured or fractured joints and bones. They help to immobilize broken bones or dislocated joints in place, until fully healed. A cast is the treatment of choice in fractures where a minimal amount of swelling is expected, including fractures that are non-displaced as well as complicated conditions such as Paige’s, wherein a cast is placed after subsided swelling due to initial
More Releases for IUD
Global Intrauterine Contraceptive Devices (IUD) Market is anticipated to shoot o …
Description The Global Intrauterine Contraceptive Devices (IUD) Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 growing at a CAGR of XX% during the forecast period. IUDs are small contraceptive devices, often T-shaped, containing either copper or levonorgestrel, helping in birth control for an extended period of time. They are a form of long-acting contraception and are the most effective type of
Intrauterine Contraceptive Devices (IUD) Market is expected to register a CAGR c …
Marketprognosis.com Publish a New Market Research Report On “Global Intrauterine Contraceptive Devices (IUD) Market 2019 - 2023” which contains global key player’s survey information and forecast to 2023. Overview of the Global Intrauterine Contraceptive Devices (IUD) Market: The report spread across 105 pages is an overview of the Global Intrauterine Contraceptive Devices (IUD) Market. These report study based on the Intrauterine Contraceptive Devices (IUD) Market. It is a complete overview of the
Intrauterine Contraceptive Devices (IUD) Market Research, Key Players, Growth Op …
The report on Intrauterine Contraceptive Devices (IUD) Market sheds light on the important developments impacting and increasing the growth of the Intrauterine Contraceptive Devices (IUD) market including its restraints, drivers and prospects. The Intrauterine Contraceptive Devices (IUD) market report proposes complete synopsis of the market, covering several characteristics such as product definition, market breakdown based on several constraints, supply chain analysis, and the fundamental Key Players outlook. The report on Intrauterine
Intrauterine Contraceptive Devices (IUD) Market will grow at 10.0% CAGR During 2 …
Marketprognosis.com Publish a New Market Research Report On “Global Intrauterine Contraceptive Devices (IUD) Market 2018 - 2023” which contains global key player’s survey information and forecast to 2023. Overview of the Global Intrauterine Contraceptive Devices (IUD) Market: The report spread across 105 pages is an overview of the Global Intrauterine Contraceptive Devices (IUD) Market. These report study based on the Intrauterine Contraceptive Devices (IUD) Market. It is a complete overview of the
Hormonal Contraceptive Market | Worth 15.60 Billion USD By 2023 | By Product | V …
Crystal Market Research has released its latest research-based report entitled “Hormonal Contraceptive” Market. The report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the “Hormonal Contraceptive” market global along with the key trends and latest technologies, playing a prominent role in the Hormonal Contraceptive market growth over the next five years. Hormonal Contraceptive Market - Competitive Insights: The major players
IUCD Market 2018 Global Size; Approx. CAGR of 8.72% | by type Hormonal IUD, Copp …
IUCD Market – Highlight: China IUCD market was about is expected to reach US$ 250 billion by 2023 at a CAGR of 12.7% during forecast period 2017 to 2023. IUCD stands for Intra-Uterine Contraceptive Devices. It is a device inserted into the uterus to prevent pregnancy. The device is T-shaped made up of flexible plastic with a coating of thin copper wire. Get Premium Sample copy @ https://www.marketresearchfuture.com/sample_request/1306 . China, ICUD was the